[The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors]. 1989

K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn

The activation of coagulation and fibrinolysis as well as coagulation inhibitors in the blood of patients with compensated (n = 25) and decompensated (n = 25) liver cirrhosis were studied. Protein C (PC) was decreased in a more pronounced manner than antithrombin III (AT III) in liver cirrhosis. Thereby, PC proved to be a highly sensible indicator of liver cell dysfunction. Decreased levels of PC activity (PC ratio activity/antigen 0.82) in decompensated liver cirrhosis suggest production of dysfunctional, undercarboxylated PC. We observed increased blood concentrations of fibrinopeptide A (FPA) (p less than 0.05) in both groups of patients compared to healthy volunteers (n = 25), while D-Dimer was increased only in patients with decompensated liver cirrhosis (p less than 0.01). Comparing both groups of patients. D-Dimer was significantly different with higher levels in decompensated liver cirrhosis (p less than 0.01). The ratio D-Dimer/FPA was significantly increased in decompensated liver cirrhosis compared to both other groups. These observations indicate that efflux from the extravascular space, e.g. ascitic fluid, contributes to the high contents of fibrin degradation products (D-Dimer) in patients with decompensated liver cirrhosis. In summary we conclude that patients with liver cirrhosis have enhanced activation of both coagulation and fibrinolysis but that the balance is not significantly displaced.

UI MeSH Term Description Entries
D008104 Liver Cirrhosis, Alcoholic FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING. Alcoholic Cirrhosis,Hepatic Cirrhosis, Alcoholic,Alcoholic Hepatic Cirrhosis,Alcoholic Liver Cirrhosis
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
October 1970, Polski przeglad chirurgiczny,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
March 1991, Journal of Korean medical science,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
November 1997, Annals of the Academy of Medicine, Singapore,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
May 1974, Nihon rinsho. Japanese journal of clinical medicine,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
June 1991, Gematologiia i transfuziologiia,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
March 1970, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
January 1998, Alcohol (Fayetteville, N.Y.),
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
March 2022, Thrombosis and haemostasis,
K H Zurborn, and J Gram, and E Rohwedder, and B Bewig, and H D Bruhn
January 1973, Psychiatria polska,
Copied contents to your clipboard!